208 related articles for article (PubMed ID: 37907991)
1. Changes of immune microenvironment in head and neck squamous cell carcinoma in 3D-4-culture compared to 2D-4-culture.
Xiao J; Song Y; Gao R; You M; Deng C; Tan G; Li W
J Transl Med; 2023 Oct; 21(1):771. PubMed ID: 37907991
[TBL] [Abstract][Full Text] [Related]
2. Cultivation of Head and Neck Squamous Cell Carcinoma Cells with Wound Fluid Leads to Cisplatin Resistance via Epithelial-Mesenchymal Transition Induction.
Meyer TJ; Stöth M; Moratin H; Ickrath P; Herrmann M; Kleinsasser N; Hagen R; Hackenberg S; Scherzad A
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922946
[TBL] [Abstract][Full Text] [Related]
3. EMT-related transcription factors and protein stabilization mechanisms involvement in cadherin switch of head and neck squamous cell carcinoma.
Ingruber J; Dudás J; Savic D; Schweigl G; Steinbichler TB; Greier MDC; Santer M; Carollo S; Trajanoski Z; Riechelmann H
Exp Cell Res; 2022 May; 414(1):113084. PubMed ID: 35219646
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
St John MA
Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
[TBL] [Abstract][Full Text] [Related]
5. Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression.
Umbreit C; Flanjak J; Weiss C; Erben P; Aderhold C; Faber A; Stern-Straeter J; Hoermann K; Schultz JD
Anticancer Res; 2014 Dec; 34(12):7061-9. PubMed ID: 25503133
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion.
Sarnella A; Ferrara Y; Auletta L; Albanese S; Cerchia L; Alterio V; De Simone G; Supuran CT; Zannetti A
J Exp Clin Cancer Res; 2022 Apr; 41(1):122. PubMed ID: 35365193
[TBL] [Abstract][Full Text] [Related]
7. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma.
Lai YJ; Yu WN; Kuo SC; Ho CT; Hung CM; Way TD; Chen CT
J Cell Physiol; 2019 Jun; 234(6):9118-9129. PubMed ID: 30341909
[TBL] [Abstract][Full Text] [Related]
8. Induction of epithelial-mesenchymal transition (EMT) and Gli1 expression in head and neck squamous cell carcinoma (HNSCC) spheroid cultures.
Essid N; Chambard JC; Elgaaïed AB
Bosn J Basic Med Sci; 2018 Nov; 18(4):336-346. PubMed ID: 30172250
[TBL] [Abstract][Full Text] [Related]
9. The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma.
Chen SF; Nieh S; Jao SW; Wu MZ; Liu CL; Chang YC; Lin YS
J Pathol; 2013 Oct; 231(2):180-9. PubMed ID: 23775566
[TBL] [Abstract][Full Text] [Related]
10. Irradiated fibroblasts increase interleukin-6 expression and induce migration of head and neck squamous cell carcinoma.
Suzuki S; Toyoma S; Kawasaki Y; Yamada T
PLoS One; 2022; 17(1):e0262549. PubMed ID: 35089951
[TBL] [Abstract][Full Text] [Related]
11. Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt.
Kuo SZ; Blair KJ; Rahimy E; Kiang A; Abhold E; Fan JB; Wang-Rodriguez J; Altuna X; Ongkeko WM
BMC Cancer; 2012 Nov; 12():556. PubMed ID: 23176396
[TBL] [Abstract][Full Text] [Related]
12. Interactions of human MSC with head and neck squamous cell carcinoma cell line PCI-13 reduce markers of epithelia-mesenchymal transition.
Böhrnsen F; Fricke M; Sander C; Leha A; Schliephake H; Kramer FJ
Clin Oral Investig; 2015 Jun; 19(5):1121-8. PubMed ID: 25346374
[TBL] [Abstract][Full Text] [Related]
13. IL-6 antisense-mediated growth inhibition in a head and neck squamous cell carcinoma cell line.
Bran G; Götte K; Riedel K; Hörmann K; Riedel F
In Vivo; 2011; 25(4):579-84. PubMed ID: 21708999
[TBL] [Abstract][Full Text] [Related]
14. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways.
Way TD; Huang JT; Chou CH; Huang CH; Yang MH; Ho CT
Eur J Cancer; 2014 Jan; 50(2):366-78. PubMed ID: 24157255
[TBL] [Abstract][Full Text] [Related]
15. Tumor-derived exosomes elicit cancer-associated fibroblasts shaping inflammatory tumor microenvironment in head and neck squamous cell carcinoma.
Mito I; Takahashi H; Kawabata-Iwakawa R; Horikawa M; Ida S; Tada H; Matsuyama T; Misawa K; Takeda S; Chikamatsu K
Oral Oncol; 2023 Jan; 136():106270. PubMed ID: 36462328
[TBL] [Abstract][Full Text] [Related]
16. Suppression of migration, invasion, and metastasis of cisplatin-resistant head and neck squamous cell carcinoma through IKKβ inhibition.
Liao J; Yang Z; Carter-Cooper B; Chang ET; Choi EY; Kallakury B; Liu X; Lapidus RG; Cullen KJ; Dan H
Clin Exp Metastasis; 2020 Apr; 37(2):283-292. PubMed ID: 32020377
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-21 promotes head and neck squamous cell carcinoma (HNSCC) induced transition of bone marrow mesenchymal stem cells to cancer-associated fibroblasts.
Wang H; Zhou Z; Lin W; Qian Y; He S; Wang J
BMC Cancer; 2023 Nov; 23(1):1135. PubMed ID: 37993769
[TBL] [Abstract][Full Text] [Related]
18. Stable SET knockdown in head and neck squamous cell carcinoma promotes cell invasion and the mesenchymal-like phenotype in vitro, as well as necrosis, cisplatin sensitivity and lymph node metastasis in xenograft tumor models.
Sobral LM; Sousa LO; Coletta RD; Cabral H; Greene LJ; Tajara EH; Gutkind JS; Curti C; Leopoldino AM
Mol Cancer; 2014 Feb; 13():32. PubMed ID: 24555657
[TBL] [Abstract][Full Text] [Related]
19. CSRP2 promotes cell stemness in head and neck squamous cell carcinoma.
Zhang MJ; Liu J; Wan SC; Li JX; Wang S; Fidele NB; Huang CF; Sun ZJ
Head Neck; 2023 Sep; 45(9):2161-2172. PubMed ID: 37466293
[TBL] [Abstract][Full Text] [Related]
20. FUT6 inhibits the proliferation, migration, invasion, and EGF-induced EMT of head and neck squamous cell carcinoma (HNSCC) by regulating EGFR/ERK/STAT signaling pathway.
Wang Q; Liao C; Tan Z; Li X; Guan X; Li H; Tian Z; Liu J; An J
Cancer Gene Ther; 2023 Jan; 30(1):182-191. PubMed ID: 36151332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
